Illustration: Sarah Grillo/Axios
Flagship Pioneering unveiled its latest offshoot — Expedition Medicines, equipped with $50 million in Series A financing.
Why it matters: Expedition is already fundraising a Series B as it scales its drug discovery platform, says CEO Molly Gibson.